Insights that Echo Beyond the Echo Chamber
The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded as Zoryve for the skin condition seborrheic dermatitis in people aged nine years and up.
Ashley Davidson, vice president of sponsor and tech strategy at Advarra, discusses her outlook for this year’s edition of the…
This startup, born out of AION Labs’ startup challenge, aims to enhance the development of biological therapeutics by using the…
We caught up with the company once more and put a few more questions to CEO Sebastian Coppe about the…